Chandar Mohan Batra
YOU?
Author Swipe
View article: A Case Report of Tumor Induced Osteomalacia Due to Mesenchymal Tumor in the Temporal Bone
A Case Report of Tumor Induced Osteomalacia Due to Mesenchymal Tumor in the Temporal Bone Open
Tumor Induced Osteomalacia (TIO) is a paraneoplastic syndrome characterized by renal phosphate wasting due to excess production of fibroblast growth factor (FGF23). The average lag period between the initial clinical manifestations and the…
View article: Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab
Spontaneous Hypoglycaemia due to Insulin Autoimmune Syndrome in Six Cases, Response to Steroid Therapy and Rituximab Open
Introduction: Dr. Hirata of Japan first described insulin autoimmune syndrome (IAS) in 1970. Seven hundred ninety-five cases of this rare syndrome have been reported from Japan and China and 29 from India. IAS has the following characteris…
View article: Tumor-induced osteomalacia due to a phosphaturic mesenchymal maxillary tumor
Tumor-induced osteomalacia due to a phosphaturic mesenchymal maxillary tumor Open
Tumor-induced osteomalacia is a rare paraneoplastic syndrome with hypophosphatemia due to renal phosphate wasting. The clinical presentation is bony pains and muscle wasting. A 23-year-old male presented to us in a wheelchair with joint pa…
View article: Bilateral Synchronous Robotic-Assisted Adrenalectomies in a Patient of Bilateral Pheochromocytoma and Von Hippel–Lindau Disease – A Rewarding Approach
Bilateral Synchronous Robotic-Assisted Adrenalectomies in a Patient of Bilateral Pheochromocytoma and Von Hippel–Lindau Disease – A Rewarding Approach Open
Hypertensive crisis is rare in children. Among the rarest causes leading to this acute crisis, is bilateral adrenal tumour as a part of a syndrome, Von Hippel Lindau syndrome. The treatment is based on the excision of the adrenal tumour fo…
View article: D1 MTE1 Case 1: Steroid refractory insulin autoimmune syndrome treated with rituximab and continuous glucose monitoring
D1 MTE1 Case 1: Steroid refractory insulin autoimmune syndrome treated with rituximab and continuous glucose monitoring Open
A 67-year-old female presented with severe hypoglycaemia with a blood glucose of 34mg/dl 5 hours after having dinner. She did not have diabetes and had no access to oral hypoglycaemic agents, insulin, or any other drug known to cause hypog…
View article: Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring
Steroid-Refractory Insulin Autoimmune Syndrome Treated With Rituximab and Continuous Glucose Monitoring Open
View article: Effect of oral versus intramuscular Vitamin D replacement in apparently healthy adults with Vitamin D deficiency
Effect of oral versus intramuscular Vitamin D replacement in apparently healthy adults with Vitamin D deficiency Open
Both oral and IM routes are effective for the treatment of Vitamin D deficiency. 25-hydroxyvitamin D levels in the IM cholecalciferol group showed a sustained increase from baseline.